| Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants JP Morello, A Salahpour, A Laperrière, V Bernier, MF Arthus, M Lonergan, ... The Journal of clinical investigation 105 (7), 887-895, 2000 | 651 | 2000 |
| Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome AL Sellier-Leclerc, V Fremeaux-Bacchi, MA Dragon-Durey, MA Macher, ... Journal of the American Society of Nephrology 18 (8), 2392-2400, 2007 | 527 | 2007 |
| Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome M Lemaire, V Frémeaux-Bacchi, F Schaefer, M Choi, WH Tang, ... Nature genetics 45 (5), 531-536, 2013 | 517 | 2013 |
| Renal phenotypes related to hepatocyte nuclear factor-1β (TCF2) mutations in a pediatric cohort T Ulinski, S Lescure, S Beaufils, V Guigonis, S Decramer, D Morin, ... Journal of the American Society of Nephrology 17 (2), 497-503, 2006 | 306 | 2006 |
| Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus MJ CRUMLEY, AK NAUMOVA, D MORIN, LA DE MARCO, BS KAPLAN, ... Journal of the American Society of Nephrology 11 (6), 1044-1054, 2000 | 208 | 2000 |
| Phenotype–genotype correlation in antenatal and neonatal variants of Bartter syndrome K Brochard, O Boyer, A Blanchard, C Loirat, P Niaudet, MA Macher, ... Nephrology Dialysis Transplantation 24 (5), 1455-1464, 2009 | 173 | 2009 |
| Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients C Couchoud, F Bayer, C Ayav, C Béchade, P Brunet, F Chantrel, L Frimat, ... Kidney international 98 (6), 1519-1529, 2020 | 139 | 2020 |
| Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. Y Ala, D Morin, B Mouillac, N Sabatier, R Vargas, N Cotte, M Déchaux, ... Journal of the American Society of Nephrology 9 (10), 1861-1872, 1998 | 138 | 1998 |
| Quality of life of children and adolescents after kidney or liver transplantation: child, parents and caregiver's point of view S Manificat, A Dazord, P Cochat, D Morin, F Plainguet, D Debray Pediatric transplantation 7 (3), 228-235, 2003 | 133 | 2003 |
| A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison … CB Langman, LA Greenbaum, M Sarwal, P Grimm, P Niaudet, ... Clinical Journal of the American Society of Nephrology 7 (7), 1112-1120, 2012 | 104 | 2012 |
| Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus F Jean-Alphonse, S Perkovska, MC Frantz, T Durroux, C Méjean, D Morin, ... Journal of the American Society of Nephrology 20 (10), 2190-2203, 2009 | 102 | 2009 |
| The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist … D Morin, N Cotte, MN Balestre, B Mouillac, M Manning, C Breton, ... FEBS letters 441 (3), 470-475, 1998 | 99 | 1998 |
| CKD and its risk factors among patients with cystinuria C Prot-Bertoye, S Lebbah, M Daudon, I Tostivint, P Bataille, F Bridoux, ... Clinical Journal of the American Society of Nephrology 10 (5), 842-851, 2015 | 94 | 2015 |
| Mutation Update of the CLCN5 Gene Responsible for Dent Disease 1 L Mansour‐Hendili, A Blanchard, N Le Pottier, I Roncelin, S Lourdel, ... Human mutation 36 (8), 743-752, 2015 | 89 | 2015 |
| Molecular pharmacology of AVP and OT receptors and therapeutic potential C Barberis, D Morin, T Durroux, B Mouillac, G Guillon, R Seyer, M Hibert, ... Drug News & Perspectives 12 (5), 279, 1999 | 80 | 1999 |
| Conserved aromatic residues in the transmembrane region VI of the V1a vasopressin receptor differentiate agonist vs. antagonist ligand binding N Cotte, MN Balestre, A Aumelas, E Mahé, S Phalipou, D Morin, M Hibert, ... European Journal of Biochemistry 267 (13), 4253-4263, 2000 | 78 | 2000 |
| Prospective, randomized trial comparing short and long intravenous antibiotic treatment of acute pyelonephritis in children: dimercaptosuccinic acid scintigraphic evaluation at … F Bouissou, C Munzer, S Decramer, B Roussel, R Novo, D Morin, ... Pediatrics 121 (3), e553-e560, 2008 | 77 | 2008 |
| Direct identification of human oxytocin receptor-binding domains using a photoactivatable cyclic peptide antagonist: comparison with the human V1a vasopressin receptor C Breton, H Chellil, M Kabbaj-Benmansour, E Carnazzi, R Seyer, ... Journal of Biological Chemistry 276 (29), 26931-26941, 2001 | 69 | 2001 |
| Schimke immunoosseous dysplasia: suggestions of genetic diversity JM Clewing, H Fryssira, D Goodman, SF Smithson, EA Sloan, S Lou, ... Human mutation 28 (3), 273-283, 2007 | 68 | 2007 |
| Prevalence of novel MAGED2 mutations in antenatal Bartter syndrome A Legrand, C Treard, I Roncelin, S Dreux, A Bertholet-Thomas, F Broux, ... Clinical journal of the American Society of Nephrology 13 (2), 242-250, 2018 | 67 | 2018 |
